ABOUT
Our Company - Global
Our Technology
Distributors & OEM
Gentian Nordics
Gentian North America
Gentian 中国
Careers
PRODUCTS
GCAL® Calprotectin
Cystatin C
Retinol-Binding Protein
Canine CRP
NT-proBNP Pre-Launch
BÜHLMANN Products
IFU Documents
Safety Data Sheets
INSIGHTS
INVESTORS
Key information
Share information
Reports & presentations
Financial calendar
General meeting
Corporate governance
Investor news
IR contact
NEWS
CONTACT
Menu
ABOUT
Our company
Our Technology
Distributors & OEM
Gentian Nordics
Gentian North America
Gentian 中国
Careers
PRODUCTS
GCAL® Calprotectin
Cystatin C
Retinol-Binding Protein
Canine CRP
NT-proBNP Pre-launch
BÜHLMANN Products
IFU Documents
Safety Data Sheets
INSIGHTS
INVESTORS
Key information
Share information
Reports & presentations
Financial calendar
General meeting
Corporate governance
Investor News
IR contact
NEWS
CONTACT
SEARCH
INVESTOR NEWS
Mar 22, 2023
Health economic model identifies GCAL® as a cost-effective biomarker
Moss, 22 March 2023
Aug 25, 2021
Second quarter 2021 report
Moss, 25 August 2021:
Mar 28, 2019
Gentian Diagnostics appoints Torsten Knüttel as VP Reseach & Development
Moss, 28.03.19
Previous